Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis C.G. Baxter, D.W. Denning, A.M.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Circulating levels of sTNFR and discrepancy between cytotoxicity and immunoreactivity of TNF-α in patients with visceral leishmaniasis I.M. Medeiros,

L. Boyanova Clinical Microbiology and Infection

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome J. Guinea, M. Torres-Narbona, P.

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

A serosurvey of Orientia tsutsugamushi from patients with scrub typhus

Virological tools to diagnose and monitor hepatitis C virus infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Prevalence of Toscana virus antibodies in residents of Croatia

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Comparison of two fluorescent whiteners, Calcofluor and Blankophor, for the detection of fungal elements in clinical specimens in the diagnostic laboratory

Vector control: a cornerstone in the malaria elimination campaign

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

B. Gordts Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

L. Arreaza, J.A. Vázquez Clinical Microbiology and Infection

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

J. Garau Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients S. Oliveri, L. Trovato, P. Betta, M.G. Romeo,

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal.

Update on invasive aspergillosis: clinical and diagnostic aspects

In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† C.B. Moore,

J.L. Balcázar Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis C.G. Baxter, D.W. Denning, A.M. Jones, A. Todd, C.B. Moore, M.D. Richardson Clinical Microbiology and Infection Volume 19, Issue 4, Pages E197-E204 (April 2013) DOI: 10.1111/1469-0691.12133 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Correlation between ImmunoCap and Platelia Aspergillus IgG levels and precipitin (CIE) titre. There was one precipitin titre of 32, which has not been included in the figures due to scale: the ImmunoCap IgG level was 76 mg/L while the Platelia IgG was >80 AU/mL. Clinical Microbiology and Infection 2013 19, E197-E204DOI: (10.1111/1469-0691.12133) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Correlation between ImmunoCap and Platelia Aspergillus IgG concentrations. All 15 ImmunoCap results with a titre of >200 mg/L had a Platelia IgG concentration >80 AU/mL. For Platelia results >80 AU/mL there was a wide variation of ImmunoCap results (45–200 mg/L). Clinical Microbiology and Infection 2013 19, E197-E204DOI: (10.1111/1469-0691.12133) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Distribution of Aspergillus IgG concentrations in each patient group. Where the number of patients with a particular IgG concentration is indistinct, these have been labelled. Clinical Microbiology and Infection 2013 19, E197-E204DOI: (10.1111/1469-0691.12133) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions